ADC Therapeutics SA (ADCT)
4.17
+0.13
(+3.22%)
USD |
NYSE |
May 15, 15:22
ADC Therapeutics Market Cap: 401.26M for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 388.75M |
| May 13, 2024 | 403.19M |
| May 10, 2024 | 413.77M |
| May 09, 2024 | 439.75M |
| May 08, 2024 | 424.36M |
| May 07, 2024 | 399.99M |
| May 06, 2024 | 368.52M |
| May 03, 2024 | 405.79M |
| May 02, 2024 | 391.71M |
| May 01, 2024 | 390.05M |
| April 30, 2024 | 365.21M |
| April 29, 2024 | 372.66M |
| April 26, 2024 | 359.41M |
| April 25, 2024 | 367.69M |
| April 24, 2024 | 395.85M |
| April 23, 2024 | 411.59M |
| April 22, 2024 | 387.57M |
| April 19, 2024 | 390.88M |
| April 18, 2024 | 394.19M |
| April 17, 2024 | 410.76M |
| April 16, 2024 | 367.69M |
| April 15, 2024 | 361.90M |
| April 12, 2024 | 363.55M |
| April 11, 2024 | 387.40M |
| April 10, 2024 | 389.88M |
| Date | Value |
|---|---|
| April 09, 2024 | 395.68M |
| April 08, 2024 | 421.34M |
| April 05, 2024 | 413.89M |
| April 04, 2024 | 389.88M |
| April 03, 2024 | 366.70M |
| April 02, 2024 | 356.77M |
| April 01, 2024 | 367.53M |
| March 28, 2024 | 370.56M |
| March 27, 2024 | 346.62M |
| March 26, 2024 | 359.00M |
| March 25, 2024 | 346.62M |
| March 22, 2024 | 374.68M |
| March 21, 2024 | 380.46M |
| March 20, 2024 | 390.36M |
| March 19, 2024 | 385.41M |
| March 18, 2024 | 363.96M |
| March 15, 2024 | 311.96M |
| March 14, 2024 | 308.66M |
| March 13, 2024 | 321.86M |
| March 12, 2024 | 367.26M |
| March 11, 2024 | 367.26M |
| March 08, 2024 | 371.38M |
| March 07, 2024 | 410.17M |
| March 06, 2024 | 412.65M |
| March 05, 2024 | 397.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.75M
Minimum
Nov 09 2023
3.610B
Maximum
Jul 02 2020
1.177B
Average
704.51M
Median
Jul 07 2022
Market Cap Benchmarks
| Roche Holding AG | 200.27B |
| Novartis AG | 210.20B |
| AC Immune SA | 346.15M |
| CRISPR Therapeutics AG | 4.829B |
| Addex Therapeutics Ltd | 9.780M |
Market Cap Related Metrics
| PS Ratio | 4.992 |
| PEG Ratio | -0.1517 |
| Price | 4.17 |
| Earnings Yield | -66.43% |
| PEGY Ratio | -0.1517 |